Therefore, we discovered that the dephosphorylation of Cav-1 can be achieved using pharmacological stimulation of the potassium channel Kv11.1, which is uniquely and highly expressed in MDA-MB-231 triple negative breast cancer cells. This evidence concerns the gene CAV1 and triple-negative breast carcinoma.